CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 67 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $379,000 | -1.8% | 25,000 | -13.8% | 0.02% | +30.8% |
Q4 2014 | $386,000 | +2.1% | 29,000 | -3.3% | 0.01% | +44.4% |
Q3 2014 | $378,000 | +1.1% | 30,000 | -18.9% | 0.01% | +12.5% |
Q2 2014 | $374,000 | -40.5% | 37,000 | -20.9% | 0.01% | -38.5% |
Q1 2014 | $629,000 | – | 46,800 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
L1 Capital Pty Ltd | 1,149,120 | $14,559,000 | 2.72% |
Corriente Advisors, LLC | 680,000 | $8,595,000 | 2.05% |
ACUTA CAPITAL PARTNERS, LLC | 537,500 | $6,794,000 | 1.85% |
INGALLS & SNYDER LLC | 1,362,203 | $17,218,000 | 0.85% |
Kensington Investment Counsel, LLC | 75,533 | $955,000 | 0.79% |
SPHERA FUNDS MANAGEMENT LTD. | 384,039 | $4,854,000 | 0.43% |
Opaleye Management Inc. | 254,000 | $3,211,000 | 0.42% |
RA Capital Management | 1,823,520 | $23,049,000 | 0.32% |
Perceptive Advisors | 2,150,641 | $27,184,000 | 0.29% |
Parkman Healthcare Partners LLC | 50,290 | $636,000 | 0.16% |